Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Portola Pharmaceuticals Inc (PTLA_old)

NASDAQ
Currency in USD
Disclaimer
18.03
0.00(0.00%)
Closed
PTLA_old Scorecard
Fair Value
Unlock Value
Day's Range
17.9918.07
52 wk Range
0.0018.07
Prev. Close
18.03
Open
18
Day's Range
17.99-18.07
52 wk Range
0-0
Volume
0
Average Volume (3m)
957,891
1-Year Change
0%
Shares Outstanding
78,517,282
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about PTLA_old?
Vote to see community's results!
or

Portola Company Profile

Portola Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops and commercializes novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation in Europe and the United States. It produces Andexxa, an antidote for the treatment of rivaroxaban and apixaban under the Ondexxya brand; Bevyxxa (betrixaban), an oral, once-daily Factor Xa inhibitor for the prevention of venous thromboembolism in adult patients for an acute medical illness; cerdulatinib, an investigational oral, dual spleen tyrosine kinase; and Janus kinases inhibitor for the treatment of hematologic cancers. The company was incorporated in 2003 and is based in South San Francisco, California. As of July 1, 2020, Portola Pharmaceuticals, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.